Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.

Recruiting now

Conditions studied: Low Risk Differentiated Thyroid Cancer

In brief

This study aims to assess the feasibility of a shared-care model for low-risk differentiated thyroid cancer (DTC) patients, primary care practitioners (PCPs) and the tertiary care center utilizing a digital health-based thyroid cancer assessment reminder system (TCARS) in Medable with an expedited referral to specialists for rapid assessment in case of a concern of recurrence.

Key facts

Study ID

NCT05510934

Run by

Nova Scotia Health Authority

People needed

60

Starts

2022-09-30

Expected to finish

2025-12-30

Last updated by the study team

2024-08-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (>18 years old) consenting patients being followed at the Halifax Interdisciplinary Thyroid Oncology Clinic (ITOC) meeting the following criteria:
• AJCC stage 1 DTC with no radiological or biochemical evidence of thyroid cancer with undetectable high sensitivity serum thyroglobulin (hsTG <0.06 mcg/L*);
• Anti-thyroglobulin antibody (anti-TG AB <20 IU/ml*);
• Thyroid ultrasound scan [USS] negative for regional recurrence at least 24 months after most recent treatment;
• AJCC stage 2 DTC with no radiological or biochemical evidence of cancer (undetectable hsTG and anti-TG AB and negative thyroid USS) at least 48 months after most recent treatment
• Patient is comfortable with using the mobile or Medable application and has access to internet.

You may not qualify if…

• Patient does not have a consented PCP.

Where it is running

• Nova Scotia Health — Halifax, Nova Scotia, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.